-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On the evening of May 18, CDE issued a notice on the public testing of the patent information registration platform related to the early resolution of drug patent disputes, and officially launched the online test of the "China Listed Drug Patent Information Registration Platform", which also marks China's drug patents.
On the evening of May 18, CDE issued a notice on the public testing of the patent information registration platform related to the early resolution of drug patent disputes, and officially launched the online test of the "China Listed Drug Patent Information Registration Platform", which also marks China's drug patents.
In order to implement the "Opinions on Deepening the Reform of the Review and Approval System to Encourage Innovation in Drugs and Medical Devices" and the relevant provisions of the Patent Law, the State Food and Drug Administration has actively promoted the formulation and promulgation of implementation measures for the early resolution of drug patent disputes in conjunction with relevant departments.
Please actively participate in the registration test of relevant drug patent information for the marketing authorization holders of drugs that have been marketed in China.
Thank you for your participation and great support.
Drug Evaluation Center of the State Drug Administration
May 18, 2021
